Subscribe
Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

JAMA Editor’s Summary

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue
November 5, 2019
ADVERTISEMENT
WP Engine Wordpress Hosting

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Making the World a Healthier Place with AI and Data Mary Claire Duch, President of W2O pure & Jonathan Woodring, EVP & GM of IPM.ai